New hope for endometriosis sufferers: phase 3 trial launches
Symptom relief
Not yet recruiting
This study tests a new drug called HMI-115 to see if it can reduce pain in women with moderate to severe endometriosis. About 540 women aged 18-49 with surgically confirmed endometriosis will receive either the drug or a placebo for 24 weeks, with an optional 28-week extension. T…
Phase: PHASE3 • Sponsor: Hope Medicine (Nanjing) Co., Ltd • Aim: Symptom relief
Last updated May 26, 2026 10:48 UTC